Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.


TSX:EDT - Post by User

User Avatar Image
(284)
•••
  • BlueJays9293X
Comment by BlueJays9293on Sep 11, 2025 6:30pm
114 Views
Post# 36711601

RE:RE: i-Dialco Inc

RE:RE: i-Dialco IncMe either Hmmm, but it's good to see such shareholder awareness as we count down the days until Spectral gets gobbled up.  It was similar to when shareholders where in disbelief that they actually did it after top-line #'s slowly sunk in, and so they started double checking that the ip-rights were all in order, which of course they are to the most utmost degree. 

Just the patents on the manufacturing process alone will protect her for 2 decades if not more, and that's if a copycat could even figure out the insane manufacturing process to begin with.  Oh and after that, they'd have to run phase 3 trials to prove that it's perfectly comparable to Toraymyxin. 

I like looking at the direction of the wind, by looking at the "3 Month Closes" tab on Stockwatch, to me she's temporarily been range bound by $1.70 if you need to unload a slug, and $1.75 if you're wanting to add another slug, we'll see how long she graze's here.


<< Previous
Bullboard Posts
Next >>